/Users/andrea/_magisterarbeit/korpus/clean/testkorpus/34/file_190l.html NN ----------------------------------------- : Ban NP direct JJ drug NN advertising NN . SENT To TO the DT editor NN . SENT I PP am VBP a DT retired JJ family NN physician NN whose WP$ only RB current JJ contact NN with IN drug NN companies NNS is VBZ as IN a DT consumer NN . SENT I PP spent VVD 15 CD years NNS as IN a DT practitioner NN , , 16 CD years NNS as IN a DT residency NN director NN I PP was VBD a DT RAP NN consultant NN for IN eight CD years NNS and CC then RB 10 CD years NNS as IN a DT full JJ time NN investigator NN for IN clinical JJ drug NN trials NNS . SENT One CD thing NN that IN I PP learned VVD during IN my PP$ research NN years NNS is VBZ that DT drug NN pricing NN is VBZ based VVN on IN what WP the DT market NN will MD bear VV not RB on IN the DT cost NN of IN development NN . SENT I PP heard VVD one CD vice NN president NN of IN a DT major JJ drug NN company NN state NN this DT in IN a DT closed JJ meeting NN . SENT A DT major JJ portion NN of IN current JJ drug NN pricing NN is VBZ the DT cost NN of IN advertising NN prescription NN drugs NNS to TO the DT public NN . SENT This DT practice NN should MD be VB outlawed VVN , , and CC it PP is VBZ an DT area NN where WRB practicing VVG physicians NNS can MD make VV an DT impact NN . SENT Physician NN organizations NNS , , such JJ as IN AAFP NP , , should MD recommend VV to TO their PP$ members NNS that IN they PP not RB prescribe VVP such JJ drugs NNS if IN other JJ drugs NNS can MD be VB substituted VVN without IN influencing VVG quality NN of IN care NN . SENT Frank NP Snyder NP , , M NP . SENT D SYM . SENT Albuquerque NP , , N NP . SENT M NP . SENT